Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Finland

 

Strand Medical CEO on why costs differ so much globally

Why do the prices of medical procedures vary so much globally? We talk to Jussi Rantanen, CEO at Strand Medical, a consultancy that specialises in analysing the cost and the quality of care internationally. An orthopaedic surgeon, here is his take on the differences.

Analysis: which listed care providers are recovering best?

Why are listed Nordic care providers' share prices seeing a faster recovery than other European counter parts? And how has each operator weathered the storm? HBI takes a deep dive into the financials to deliver an exclusive analysis as providers prepare their Q3 results.

Scandinavian social care specialist buys big in Finland

eQ Care special investment fund has signed an agreement to sell a substantial portfolio of healthcare properties, predominantly elderly and special care homes, to a Scandinavian property fund with a focus on social care.

HBI updates dental market forecasts as operators face second wave

Dental markets have reopened following the pandemic peak but the impact may be felt for many months to come, not least because of a second wave winter. HBI has added new post-COVID market size data on the Intelligence platform based on conversations with operators. Most think new national lockdowns are unlikely but regional lockdowns, prolonged economic uncertainty for patients, and scared patients are all causing concern.

European operators brace for second wave

COVID's second wave looks either imminent, or is already starting to hit in many jurisdictions. Wave one saw lockdowns and closures - and not all closures were temporary. Will wave two be any different? HBI has been talking to operators across EMEA to see if forewarned is forearmed, how they predict the next few months will go, and what lessons have been learned.

Mehilainen ‘spinning off digital arm’ as Pihlajalinna deadline looms

Finnish healthcare group Mehilainen is spinning off its digital consultancy business into a separate company which would make it easier to sell off in future, a senior banker tells HBI. An analyst adds that raising cash this way makes sense considering what has happened since it offered to buy competitor Pihlajalinna.

Coronaria CEO: no plan to sell optical retail unit after ophtha merger

Finland’s fourth-largest healthcare operator, Coronaria, has built the biggest ophthalmology business in Finland and is also the largest player in rehabilitation. We talk to CEO Teppo Lindén about his plans, why he is keeping the optician arm and the impact of Covid.

Market welcomes Attendo’s H1 figures as it turns the COVID corner

Attendo's H1 results saw improvement as COVID's impact lessened. And while the effects of the pandemic clearly have had a negative impact on the listed Nordic care group, the market reacted positively. A share price which at the start of July was down over 35% on it's mid-February price rallied, and it is now just 10% down compared to its pre-COVID position.

Find Us